Novatio Ventures

Novatio Ventures Inc is a venture capital firm established in 2015 and headquartered in Toronto, Canada, with additional offices in Boston, Massachusetts, and Hong Kong. The firm specializes in seed and early-stage investments, primarily focusing on high-impact life sciences technologies, including therapeutics, diagnostics, devices, and drug delivery systems. Novatio Ventures aims to accelerate the commercialization of innovations in these sectors, targeting firms that are transitioning from preclinical proof-of-concept to validation. The firm actively collaborates with inventors, entrepreneurs, and institutions to develop and implement effective commercialization strategies, assemble management teams, and secure further capital. With an emphasis on markets in Canada, the United States, China, and South Korea, Novatio Ventures leverages its extensive industry network and collective experience to seek early exits that deliver attractive, risk-mitigated financial returns.